Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowBone Marrow CellsWhole-Body IrradiationTransplantation, AutologousLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation ChimeraBusulfanTissue DonorsHematopoietic Stem Cell TransplantationGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesHistocompatibility TestingHistocompatibilityRecurrenceLeukocyte TransfusionCyclophosphamideRadiation ChimeraBone Marrow PurgingGraft vs Tumor EffectLeukemia, Myeloid, AcuteTransplantation, IsogeneicLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHematologic NeoplasmsGraft vs Host ReactionHematopoietic Stem CellsLymphocyte DepletionHepatic Veno-Occlusive DiseaseCombined Modality TherapyMice, Inbred C57BLImmunosuppressive AgentsAcute DiseaseGraft vs Leukemia EffectLeukemia, MyeloidHematopoiesisLymphocyte TransfusionImmunosuppressionTreatment OutcomeTime FactorsChimeraGraft RejectionT-LymphocytesTransplantation ImmunologyMyelodysplastic SyndromesBone Marrow DiseasesNuclear FamilyCyclosporineKidney TransplantationSurvival AnalysisActuarial AnalysisHLA AntigensLymphoma, Non-HodgkinRetrospective StudiesHematologic DiseasesSevere Combined ImmunodeficiencyCytomegalovirus InfectionsBone Marrow ExaminationMice, Inbred BALB CFatal OutcomeCytarabineStem Cell TransplantationBone RemodelingAntineoplastic Combined Chemotherapy ProtocolsSurvival RateBone Marrow NeoplasmsFollow-Up StudiesPancytopeniaDisease-Free SurvivalLeukocyte CountHeart TransplantationSpleenGranulocyte Colony-Stimulating FactorColony-Forming Units AssayEtoposideLymphomaInfectionMultiple MyelomaFlow CytometryLung TransplantationMethotrexateLeukemia, Myelomonocytic, AcuteAntilymphocyte SerumAnemia, Refractory, with Excess of BlastsPrognosisCell DifferentiationBone DensityNeoplasm, ResidualCyclosporinsImmunophenotypingImmunocompromised HostThymus GlandCarmustineSkin Transplantation